UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
<p>Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent it. In recent medical literature, this approach is referred to as upstream treatment. The resul...
Main Authors: | E. A. Protasova, N. V. Furman, O. V. Reshet'ko |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-12-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/501 |
Similar Items
-
New perspectives of recurrent atrial fibrillation prevention in coronary heart disease patients
by: S. N. Tereshchenko, et al.
Published: (1970-01-01) -
PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION
by: N. V. Mikheeva, et al.
Published: (2015-09-01) -
ATRIAL FIBRILLATION AFTER CARDIAC SURGERY: PATHOPHYSIOLOGY AND PREVENTION TECHNIQUES
by: V. V. Lomivorotov, et al.
Published: (2017-12-01) -
SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT
by: E. A. Drozdova
Published: (2015-09-01) -
HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. V. Moiseev
Published: (2015-12-01)